Laporan Laba Rugi (TTM)
Laporan Laba Rugi Jiangsu Lanfeng Bio-chemical Co.,Ltd menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2022 01-01 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2023 01-01 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,398 | 1,342 | 1,438 | 1,404 | 1,349 | 1,444 | 1,549 | 1,627 | 1,449 | 1,445 | 1,388 | 1,148 | 1,117 | 1,742 | 1,738 | 2,064 | 2,405 | 1,793 | 1,959 | 2,140 |
| Change (%) | -4.03 | 7.14 | -2.36 | -3.91 | 7.04 | 7.29 | 5.05 | -10.93 | -0.29 | -3.96 | -17.29 | -2.70 | 55.92 | -0.21 | 18.76 | 16.52 | -25.45 | 9.25 | 9.26 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 1,178 | 1,163 | 1,263 | 1,257 | 1,250 | 1,473 | 1,583 | 1,672 | 1,504 | 1,452 | 1,407 | 1,190 | 1,155 | 1,805 | 1,811 | 2,182 | 2,503 | 1,901 | 2,058 | 2,175 |
| Change (%) | -1.28 | 8.61 | -0.47 | -0.55 | 17.81 | 7.48 | 5.60 | -10.07 | -3.41 | -3.14 | -15.41 | -2.97 | 56.31 | 0.32 | 20.51 | 14.71 | -24.05 | 8.29 | 5.64 | |
| % of Revenue | 84.26 | 86.68 | 87.87 | 89.56 | 92.70 | 102.02 | 102.20 | 102.74 | 103.74 | 100.49 | 101.35 | 103.66 | 103.37 | 103.63 | 104.17 | 105.70 | 104.05 | 106.00 | 105.07 | 101.60 |
| Gross Operating Profit | 220 | 179 | 174 | 147 | 99 | -29 | -34 | -45 | -54 | -7 | -19 | -42 | -38 | -63 | -73 | -118 | -97 | -108 | -99 | -34 |
| Change (%) | -18.77 | -2.43 | -16.00 | -32.75 | -129.65 | 16.76 | 30.61 | 21.50 | -86.85 | 162.38 | 124.70 | -10.36 | 67.91 | 14.71 | 62.24 | -17.18 | 10.41 | -7.60 | -65.55 | |
| % of Revenue | 15.74 | 13.32 | 12.13 | 10.44 | 7.30 | -2.02 | -2.20 | -2.74 | -3.74 | -0.49 | -1.35 | -3.66 | -3.37 | -3.63 | -4.17 | -5.70 | -4.05 | -6.00 | -5.07 | -1.60 |
| SG&A | 387 | 177 | 155 | 156 | 157 | 175 | 175 | 159 | 137 | 104 | 119 | 140 | 158 | 174 | 171 | 172 | 155 | 150 | 143 | 138 |
| Change (%) | -54.15 | -12.71 | 0.89 | 0.70 | 11.60 | -0.06 | -9.18 | -13.83 | -24.14 | 13.87 | 18.29 | 12.86 | 10.19 | -1.86 | 0.59 | -9.74 | -3.43 | -4.52 | -3.65 | |
| % of Revenue | 27.65 | 13.21 | 10.76 | 11.12 | 11.65 | 12.15 | 11.32 | 9.79 | 9.47 | 7.20 | 8.54 | 12.21 | 14.17 | 10.01 | 9.85 | 8.34 | 6.46 | 8.37 | 7.31 | 6.45 |
| R&D | 23 | 16 | 14 | 12 | 15 | 13 | 11 | 8 | 5 | 12 | 13 | 14 | 15 | 15 | 40 | 49 | 68 | 69 | 57 | 65 |
| Change (%) | -31.91 | -13.58 | -15.00 | 25.92 | -12.12 | -16.68 | -24.80 | -37.67 | 130.97 | 12.78 | 5.87 | 7.83 | 1.70 | 160.13 | 22.51 | 40.51 | 0.54 | -16.33 | 12.37 | |
| % of Revenue | 1.67 | 1.18 | 0.96 | 0.83 | 1.09 | 0.89 | 0.69 | 0.50 | 0.35 | 0.81 | 0.95 | 1.21 | 1.34 | 0.88 | 2.28 | 2.36 | 2.84 | 3.83 | 2.93 | 3.02 |
| OpEx | 1,594 | 1,366 | 1,441 | 1,437 | 1,436 | 1,668 | 1,776 | 1,844 | 1,650 | 1,574 | 1,543 | 1,350 | 1,332 | 1,999 | 2,021 | 2,405 | 2,729 | 2,123 | 2,268 | 2,383 |
| Change (%) | -14.26 | 5.50 | -0.33 | -0.02 | 16.12 | 6.47 | 3.83 | -10.51 | -4.61 | -1.99 | -12.51 | -1.30 | 50.10 | 1.09 | 19.00 | 13.44 | -22.18 | 6.81 | 5.09 | |
| % of Revenue | 113.96 | 101.81 | 100.25 | 102.33 | 106.47 | 115.50 | 114.63 | 113.30 | 113.83 | 108.90 | 111.14 | 117.57 | 119.25 | 114.80 | 116.29 | 116.53 | 113.44 | 118.41 | 115.77 | 111.36 |
| Operating Income | -195 | -24 | -4 | -33 | -87 | -224 | -227 | -216 | -200 | -129 | -155 | -202 | -215 | -258 | -283 | -341 | -323 | -330 | -309 | -243 |
| Change (%) | -87.57 | -85.11 | 804.64 | 167.04 | 156.43 | 1.22 | -4.50 | -7.38 | -35.81 | 20.18 | 30.48 | 6.62 | 19.86 | 9.86 | 20.47 | -5.23 | 2.11 | -6.43 | -21.31 | |
| % of Revenue | -13.96 | -1.81 | -0.25 | -2.33 | -6.47 | -15.50 | -14.63 | -13.30 | -13.83 | -8.90 | -11.14 | -17.57 | -19.25 | -14.80 | -16.29 | -16.53 | -13.44 | -18.41 | -15.77 | -11.36 |
| Interest Expense | -46 | -31 | -28 | -21 | -18 | -23 | -19 | -19 | -15 | -14 | -15 | -30 | -29 | -27 | -35 | -26 | -40 | -60 | -60 | -63 |
| Change (%) | -33.50 | -8.31 | -26.19 | -11.37 | 22.24 | -17.38 | 2.32 | -23.22 | -7.58 | 8.00 | 107.31 | -3.95 | -8.98 | 32.15 | -26.39 | 54.60 | 49.20 | 1.01 | 5.32 | |
| % of Revenue | -3.31 | -2.30 | -1.97 | -1.49 | -1.37 | -1.57 | -1.21 | -1.17 | -1.01 | -0.94 | -1.05 | -2.64 | -2.61 | -1.52 | -2.02 | -1.25 | -1.66 | -3.32 | -3.07 | -2.96 |
| Net Income | -533 | 15 | 31 | 11 | -38 | -491 | -492 | -479 | -461 | -321 | -336 | -411 | -445 | -332 | -348 | -380 | -381 | -253 | -244 | -158 |
| Change (%) | -102.78 | 112.32 | -65.00 | -447.33 | 1,183.99 | 0.07 | -2.51 | -3.79 | -30.44 | 4.87 | 22.16 | 8.22 | -25.26 | 4.75 | 9.17 | 0.35 | -33.78 | -3.31 | -35.32 | |
| % of Revenue | -38.14 | 1.10 | 2.19 | 0.78 | -2.84 | -34.02 | -31.73 | -29.45 | -31.81 | -22.19 | -24.23 | -35.79 | -39.80 | -19.08 | -20.03 | -18.41 | -15.85 | -14.08 | -12.46 | -7.38 |
Source: Capital IQ
